Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer-Reference-Cited by-同舟云学术

Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer

Published:2019-06-07 Issue:17 Volume:125 Page:2984-2990
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sherman Eric J.¹²^ORCID,Dunn Lara A.¹²,Schöder Heiko³,Ho Alan L.¹²,Baxi Shrujal S.¹²,Ghossein Ronald A.⁴,Haque Sofia S.³,Sima Cami⁵,Tuttle Robert Michael¹²,Pfister David G.¹²

Affiliation:

1. Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

2. Department of Medicine Weill Cornell Medicine New York New York

3. Department of Radiology Memorial Sloan Kettering Cancer Center New York New York

4. Department of Pathology Memorial Sloan Kettering Cancer Center New York New York

5. Department of Biostatistics Memorial Sloan Kettering Cancer Center New York New York

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32046

Reference26 articles.

1. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer

2. Increased Expression of the Vascular Endothelial Growth Factor Is a Pejorative Prognosis Marker in Papillary Thyroid Carcinoma

3. Systemic administration of vascular endothelial growth factor monoclonal antibody reduces the growth of papillary thyroid carcinoma in a nude mouse model;Bauer AJ;Ann Clin Lab Sci,2003

4. Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

5. Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation;American Journal of Cancer Research;2024

2. Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution;International Journal of Molecular Sciences;2022-03-30

3. Establishing Evidence for Clinical Utility of a Neuroimaging Biomarker in Major Depressive Disorder: Prospective Testing and Implementation Challenges;Biological Psychiatry;2021-08

4. Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma;Bioscience Reports;2021-04

5. A novel biosensing system based on ITO-single use electrode for highly sensitive analysis of VEGF;International Journal of Environmental Analytical Chemistry;2020-01-02